Insider Transactions in Q2 2025 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
94,906
-5.57%
|
$759,248
$8.02 P/Share
|
|
Jun 10
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
56,426
-3.21%
|
$451,408
$8.02 P/Share
|
|
May 16
2025
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
49,140
-11.22%
|
$343,980
$7.58 P/Share
|
|
May 12
2025
|
John Kiely Director |
SELL
Open market or private sale
|
Direct |
50,000
-16.26%
|
$350,000
$7.59 P/Share
|
|
May 05
2025
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+50.0%
|
-
|
|
May 05
2025
|
Shlomo Yanai Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+12.34%
|
-
|
|
May 05
2025
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+30.06%
|
-
|
|
May 05
2025
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+11.58%
|
-
|
|
May 05
2025
|
Ted C Nark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+10.56%
|
-
|
|
May 05
2025
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+16.02%
|
-
|
|
May 05
2025
|
Jeffrey P. George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+11.5%
|
-
|
|
May 05
2025
|
Paul M Meister Director |
BUY
Exercise of conversion of derivative security
|
Direct |
56,361
+6.71%
|
-
|
|
May 05
2025
|
Gautam Patel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,258
+2.24%
|
-
|
|
May 05
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
4,900
-0.28%
|
$39,200
$8.0 P/Share
|
|
May 02
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
3,768
-0.22%
|
$30,144
$8.0 P/Share
|
|
Apr 01
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
80,000
-4.42%
|
$640,000
$8.3 P/Share
|